<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01955031</url>
  </required_header>
  <id_info>
    <org_study_id>12 424 03</org_study_id>
    <secondary_id>PREPS</secondary_id>
    <nct_id>NCT01955031</nct_id>
  </id_info>
  <brief_title>Effectiveness and Cost-effectiveness of a Telemonitoring Program for Diabetic People at Home</brief_title>
  <acronym>EDUC@DOM</acronym>
  <official_title>Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severity of diabetes is related to the development of disabling and costly complications
      (12.9 billion euros in 2007). The French High Health Authority recommends a therapeutic
      education on lifestyle and dietary rules in first-line treatment of Type 2 Diabetes Mellitus.
      Despite these recommendations, patients often have difficulties to implement dietary
      recommendations every day. The objective of EDUC@DOM is to help people with diabetes to
      improve lifestyle and equilibrium of glycaemia in order to avoid or delay chronic
      complications of diabetes. Our main goal is to assess effectiveness of our telemonitoring
      program in type 2 patients' care compared to a usual care of diabetes, on the glycaemia of
      the patients. It is expected that our program leads to a better monitoring of health status,
      a greater adherence to medical and non-medical prescriptions, an empowerment of the patient,
      and as a consequence, a more efficient health care consumption.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess effectiveness of our telemonitoring program in Diabetes care, HbA1C assays will be compared between the two groups.The change of HbA1c between day 0, month 1,month 3, month 6, month 9 and month 12</measure>
    <time_frame>HbA1c will be measured at Day 0, month 1, month 3, month 6, month 9 and month 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment efficacy of our program by the measure of HbA1C will</measure>
    <time_frame>At month 15, month 18, month 21 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaires will be given to patients to assess the improvement of nutritional knowledge</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food inquiries will be given to patients to assess the improvement of eating habits</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaires will be given to patients to assess the physical activity practice</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference will be measured to assess the body composition, BMI (Body Mass Index),</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The self-monitoring blood glucose books will be copied to assess mean of blood glycaemia</measure>
    <time_frame>At day 0, month 12 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A blood sample will be collected to assess lipid status</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two questionnaires will be given to patients to assess quality of life of patients</measure>
    <time_frame>At day 0 and month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A cost-effectiveness ratio and a markov modelisation will be realized to assess the economic aspects</measure>
    <time_frame>At month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, assessment of food behavior through meals registered with the Nutri-Educ software</measure>
    <time_frame>Everytime patients use the software from Day 0 to month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, assessment of nutritional knowledge through rate of good choices playing games of Nutri-Kiosk software</measure>
    <time_frame>Everytime patients use the software from Day0 to month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, assessment of physical activity declared through Acti-Kiosk software and measures collected with the pedometer (number of steps, number of stairs climbed up)</measure>
    <time_frame>Every time patients use the software and the pedometer from day 0 to month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, measure of weight, fat rate and lean rate collected with the balance</measure>
    <time_frame>Everytime patients use the balance from day 0 to month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, means of glycaemia collected with the self-monitoring blood glucose device</measure>
    <time_frame>Everytime patients use the blood glucose device from day 0 to month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the patients with the number and time of connections and a questionnaire</measure>
    <time_frame>At month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the health professionals with the number and time of connections</measure>
    <time_frame>At month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For the telemonitoring arm, acceptability and satisfaction of the telemonitoring system by the health professionals with the number and time of connections leading to a medical decision (phone call or medical appointment) and a questionnaire</measure>
    <time_frame>At month 24</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">282</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Telemonitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with type 2 diabètes randomized in telemonitoring group have a telemonitoring device with educational Tools at their home</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patient randomized in this group have a usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>telemonitoring</intervention_name>
    <description>A telemonitoring program with educational tools is given to people with type 2 diabetes at their home. It is composed of three softwares to improve eating habits available on touchpad, a self-monitoring blood glucose device, a balance to measure weight and fat mass, and a pedometer to evaluate physical activity. Data are securely sent and stored into a web service which delivers a synthesis to patients and health professionals.</description>
    <arm_group_label>Telemonitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Patients are recruited during therapeutic educational sessions or appointments by general practitioners or diabetologists who take part into the Regional Health Network in Diabetes DIAMIP. If patients accept to participate to the study and sign up the protocol consent, they are given questionnaires about nutrition, physical activity and quality of life. A dietician analyses with each patient the results of a food inquiry. Patients are randomised into two groups: one arm is trained to the telemonitoring program before receiving it at home, and the other arm follows usual care. During 12 months, the telemonitoring group uses the device. The investigators (GP or diabetologists) can use the specific secured website to follow the measured parameters and to make appropriate decisions about health care of their patient. No consultation are scheduled in advance.</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with type 2 diabetes

          -  Older than 18 years

          -  With an insulin treatment or not

          -  Having a glycemic impairment characterized by 6.5% &lt;HbA1c ≤10

          -  Having an active internet connection at home.

          -  Accepting the terms of training, loan and use of the device

          -  Benefiting from social protection system

          -  Having given his/her free and informed consent and signed the consent

        Exclusion Criteria:

          -  Serious illness recently (&lt;3 months) or decompensated may influence glycemic control
             of the patient permanently according to the judgment of the physician in charge of
             monitoring

          -  Retinal state that does not allow optimization in equilibrium of glycaemia

          -  Known severe renal impairment defined by creatinine clearance &lt;30ml/min

          -  Known hemoglobinopathy

          -  Visual or intellectual resulting inability to use the remote monitoring tool according
             to the judgment of the physician in charge of monitoring

          -  Inability to understand all or part of the software information according to the
             judgment of the physician in charge of monitoring

          -  Subject to disabled

          -  Person with severe behavioral disorders (anorexia, bulimia, ...) according to the
             judgment of the physician in charge of monitoring

          -  Person who had, or in preparation for bariatric surgery (software nutrition education
             are not suitable for this type of care.)

          -  Person with a medical device implanted electronic pacemakers and defibrillators with
             cardiac (possibility of interference with the impedance)

          -  Another person involved in research including a period of ongoing exclusion to
             inclusion,

          -  A person under legal protection

          -  Subject living in institutions

          -  Desire for pregnancy, pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Christine TURNIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Toulouse (Rangueil and Salies-Du-Salat)</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Diabete/Donnees-epidemiologiques/Prevalence-et-incidence-du-diabete</url>
    <description>InVS (Institut de veille sanitaire). Dossier thématique. Diabète. Prévalence et incidence du diabète</description>
  </link>
  <link>
    <url>http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-chroniques-et-traumatismes/2012/Echantillon-national-temoin-representatif-des-personnes-diabetiques-Entred-2007-2010</url>
    <description>InVS (Institut de veille sanitaire). Dossier thématique. Diabète. Echantillon national témoin représentatif des personnes diabétiques (Entred) 2007-2010</description>
  </link>
  <link>
    <url>http://www.sante.gouv.fr/IMG/pdf/Rapport_final_Telemedecine.pdf</url>
    <description>Simon P, Acker D. La place de la telemedicine dans l'organisation des soins. Rapport :2008</description>
  </link>
  <reference>
    <citation>InVS (Institut de veille sanitaire). Fagot-Campagna Anne, Romon Isabelle, Fosse Sandrine, Roudier Candice. Prévalence et incidence du diabète, et mortalité liée au diabète en France Synthèse épidémiologique. Novembre 2010</citation>
  </reference>
  <reference>
    <citation>Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.</citation>
    <PMID>8366922</PMID>
  </reference>
  <reference>
    <citation>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602.</citation>
    <PMID>9742976</PMID>
  </reference>
  <reference>
    <citation>HAS (Haute Autorité de Santé). Agence Nationale de sécurité du médicament et des produits de santé. Recommandations de bonne pratique. Stratégie médicamenteuse du contrôle glycémique du diabète de type 2. Janvier 2013.</citation>
  </reference>
  <reference>
    <citation>HAS (Haute Autorité de Santé). Rapport d'orientation - Développement de la prescription de thérapeutiques non médicamenteuses validées - Avril 2011</citation>
  </reference>
  <reference>
    <citation>Trento M, Gamba S, Gentile L, Grassi G, Miselli V, Morone G, Passera P, Tonutti L, Tomalino M, Bondonio P, Cavallo F, Porta M; ROMEO Investigators. Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care. 2010 Apr;33(4):745-7. doi: 10.2337/dc09-2024. Epub 2010 Jan 26.</citation>
    <PMID>20103547</PMID>
  </reference>
  <reference>
    <citation>Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005 Jun;28(6):1510-7. Review.</citation>
    <PMID>15920083</PMID>
  </reference>
  <reference>
    <citation>Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001 Mar;24(3):561-87. Review.</citation>
    <PMID>11289485</PMID>
  </reference>
  <reference>
    <citation>INPES (Institut National de Prévention et d'Education pour la Santé). Labalette Céline, Buttet Pierre, Marchand Annie-Claude - DDESET. L'éducation thérapeutique du patient dans les schémas régionaux d'organisation sanitaire de 3e génération 2006-2011. Education thérapeutique du patient dans les Sros 3-INPES- 2007</citation>
  </reference>
  <reference>
    <citation>HAS (Haute Autorité de Santé) et INPES (Institut National de Prévention et d'Education pour la Santé). Guide Méthodologique. Structuration d'un programme d'éducation thérapeutique du patient dans le champ des maladies chroniques. Juin 2007</citation>
  </reference>
  <reference>
    <citation>MINISTÈRE DE LA SANTÉ ET DES SPORTS - Décret no 2010-904 du 2 août 2010 relatif aux conditions d'autorisation des programmes d'éducation thérapeutique du patient, - Décret no 2010-906 du 2 août 2010 relatif aux compétences requises pour dispenser l'éducation thérapeutique du patient - Arrêté du 2 août 2010 relatif aux compétences requises pour dispenser l'éducation thérapeutique du patient - Arrêté du 2 août 2010 relatif au cahier des charges des programmes d'éducation thérapeutique du patient et à la composition du dossier de demande de leur autorisation</citation>
  </reference>
  <reference>
    <citation>Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009 Oct;11(10):913-30. doi: 10.1111/j.1463-1326.2009.01057.x. Epub 2009 Jun 16. Review.</citation>
    <PMID>19531058</PMID>
  </reference>
  <reference>
    <citation>McMahon GT, Gomes HE, Hickson Hohne S, Hu TM, Levine BA, Conlin PR. Web-based care management in patients with poorly controlled diabetes. Diabetes Care. 2005 Jul;28(7):1624-9.</citation>
    <PMID>15983311</PMID>
  </reference>
  <reference>
    <citation>Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008 Jun;10(3):160-8. doi: 10.1089/dia.2008.0283.</citation>
    <PMID>18473689</PMID>
  </reference>
  <reference>
    <citation>Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, Lai AM, Field L, Morin PC, Goland R, Izquierdo RE, Ebner S, Silver S, Petkova E, Kong J, Eimicke JP; IDEATel Consortium. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446-56. doi: 10.1197/jamia.M3157. Epub 2009 Apr 23.</citation>
    <PMID>19390093</PMID>
  </reference>
  <reference>
    <citation>Young RJ, Taylor J, Friede T, Hollis S, Mason JM, Lee P, Burns E, Long AF, Gambling T, New JP, Gibson JM. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care. 2005 Feb;28(2):278-82.</citation>
    <PMID>15677779</PMID>
  </reference>
  <reference>
    <citation>Franc S., Dardari D., Boucherie B., Daoudi A., Charpentier G. La télémédecine appliquée au diabète : les résultats acquis et les perspectives à venir. Médecine des maladies Métaboliques, Vol 4, No 3, 2010.</citation>
  </reference>
  <reference>
    <citation>Kroeze W, Werkman A, Brug J. A systematic review of randomized trials on the effectiveness of computer-tailored education on physical activity and dietary behaviors. Ann Behav Med. 2006 Jun;31(3):205-23. Review.</citation>
    <PMID>16700634</PMID>
  </reference>
  <reference>
    <citation>Brug J, Oenema A, Kroeze W, Raat H. The internet and nutrition education: challenges and opportunities. Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S130-7; discussion S138-9. Review.</citation>
    <PMID>16052181</PMID>
  </reference>
  <reference>
    <citation>Paré Guy, Moqadem Khalil, Pineau Gilles, St-Hilaire Carole. Revue systématique des effets de la télésurveillance à domicile dans le contexte du diabète, des maladies pulmonaires et des maladies cardiovasculaires. AGENCE D'ÉVALUATION DES TECHNOLOGIES ET DES MODES D'INTERVENTION EN SANTÉ. Québec. ETMIS 2009; VOL. 5 : NO 3.</citation>
  </reference>
  <reference>
    <citation>Guide Affection de Longue Durée (ALD 8) - Diabète de type 2 - Guide Médecin - juillet 2007</citation>
  </reference>
  <reference>
    <citation>Buisson JC. Nutri-Educ, a nutrition software application for balancing meals, using fuzzy arithmetic and heuristic search algorithms. Artif Intell Med. 2008 Mar;42(3):213-27. doi: 10.1016/j.artmed.2007.12.001. Epub 2008 Feb 7.</citation>
    <PMID>18261889</PMID>
  </reference>
  <reference>
    <citation>Buisson J.-C., Garel A. Balancing Meals Using Fuzzy Arithmetics and Heuristic Search Algorithms. IEEE Transactions on Fuzzy Systems, IEEE, Vol. 11 N. 1, p. 68-78, 2003.</citation>
  </reference>
  <reference>
    <citation>Turnin MC, Bourgeois O, Cathelineau G, Leguerrier AM, Halimi S, Sandre-Banon D, Coliche V, Breux M, Verlet E, Labrousse F, Bensoussan D, Grenier JL, Poncet MF, Tordjmann F, Brun JM, Blickle JF, Mattei C, Bolzonella C, Buisson JC, Fabre D, Tauber JP, Hanaire-Broutin H. Multicenter randomized evaluation of a nutritional education software in obese patients. Diabetes Metab. 2001 Apr;27(2 Pt 1):139-47.</citation>
    <PMID>11353880</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care. 2010 Jan;33 Suppl 1:S11-61. doi: 10.2337/dc10-S011. Erratum in: Diabetes Care. 2010 Mar;33(3):692.</citation>
    <PMID>20042772</PMID>
  </reference>
  <reference>
    <citation>Turnin MC, Bolzonella-Pene C, Dumoulin S, Cerf I, Charpentier G, Sandre-Banon D, Valensi P, Grenier JL, Cathelineau G, Mattei C, et al. [Multicenter evaluation of the Nutri-Expert Telematic System in diabetic patients]. Diabete Metab. 1995 Feb;21(1):26-33. French.</citation>
    <PMID>7781839</PMID>
  </reference>
  <reference>
    <citation>Turnin MC, Beddok RH, Clottes JP, Martini PF, Abadie RG, Buisson JC, Soulé-Dupuy C, Bonneu M, Camaré R, Anton JP, et al. Telematic expert system Diabeto. New tool for diet self-monitoring for diabetic patients. Diabetes Care. 1992 Feb;15(2):204-12.</citation>
    <PMID>1547677</PMID>
  </reference>
  <reference>
    <citation>Couillard C, Després JP, Lamarche B, Bergeron J, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1226-32.</citation>
    <PMID>11451756</PMID>
  </reference>
  <reference>
    <citation>Haute Autorité de Santé. BON USAGE DES TECHNOLOGIES DE SANTÉ. L'autosurveillance glycémique dans le diabète de type 2 : une utilisation très ciblée. Avril 2011</citation>
  </reference>
  <reference>
    <citation>MINISTÈRE DU TRAVAIL, DE L'EMPLOI ET DE LA SANTÉ. Arrêté du 25 février 2011 relatif à la modification des conditions de prise en charge des appareils pour lecture automatique de la glycémie, dits lecteurs de glycémie, inscrits au chapitre 1er du titre Ier de la liste des produits et prestations remboursables prévue à l'article L. 165-1 du code de la sécurité sociale. JOURNAL OFFICIEL DE LA RÉPUBLIQUE FRANÇAISE. 27 février 2011</citation>
  </reference>
  <reference>
    <citation>Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C; International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002 Jan;40(1):78-89.</citation>
    <PMID>11916276</PMID>
  </reference>
  <reference>
    <citation>Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM; IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004 Jan;50(1):166-74.</citation>
    <PMID>14709644</PMID>
  </reference>
  <reference>
    <citation>Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema K, Myers G, Reinauer H, Sacks DB, Slingerland R, Siebelder C. The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem. 2008 Feb;54(2):240-8. doi: 10.1373/clinchem.2007.097402.</citation>
    <PMID>18223132</PMID>
  </reference>
  <reference>
    <citation>Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007 Sep;30(9):2399-400.</citation>
    <PMID>17726190</PMID>
  </reference>
  <reference>
    <citation>AFSSAPS. Direction de l'Evaluation des Dispositifs Médicaux, Département Surveillance du Marché, Unité Evaluation et Contrôle du Marché - DIV, Dossier suivi par Françoise Chevenne. CAHIER DES CHARGES RELATIF AUX NOTICES DES REACTIFS DOSANT L'HbA1c. Version du 10 janvier 2006</citation>
  </reference>
  <reference>
    <citation>Agence Française de Sécurité Sanitaire des Aliments (AFSSA). Avis de l'Agence française de sécurité sanitaire des aliments relatif à l'actualisation des apports nutritionnels conseillés pour les acides gras. Saisine n° 2006-SA-0359. Mars 2010</citation>
  </reference>
  <reference>
    <citation>ALFEDIAM PARAMEDICAL Recommandations de Bonnes pratiques. Alimentation du diabétique de type 2. Juin 2003</citation>
  </reference>
  <reference>
    <citation>Gautier JF. [Physical activity and type 2 diabetes]. Rev Med Liege. 2005 May-Jun;60(5-6):395-401. Review. French.</citation>
    <PMID>16035300</PMID>
  </reference>
  <reference>
    <citation>Gautier JF, Berne C, Grimm JJ, Lobel B, Coliche V, Mollet E. [Physical activity and diabetes]. Diabetes Metab. 1998 Jun;24(3):281-90. French.</citation>
    <PMID>9690065</PMID>
  </reference>
  <reference>
    <citation>HAS Traitement médicamenteux du diabète de type 2 (actualisation). Novembre 2006.</citation>
  </reference>
  <reference>
    <citation>American Diabetes Association (ADA). Physical activity/exercice and diabetes. Diabetes Care 2004, 27:S58-S62</citation>
  </reference>
  <reference>
    <citation>Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006 Jun;29(6):1433-8.</citation>
    <PMID>16732040</PMID>
  </reference>
  <reference>
    <citation>Parmenter K, Wardle J. Development of a general nutrition knowledge questionnaire for adults. Eur J Clin Nutr. 1999 Apr;53(4):298-308.</citation>
    <PMID>10334656</PMID>
  </reference>
  <reference>
    <citation>Bongard V, Ruidavets JB, Dallongeville J, Simon C, Amouyel P, Arveiler D, Ducimetière P, Ferrières J. Nutritional intakes of 1072 French free-living men with and without diagnosed cardiovascular risk factors. Eur J Clin Nutr. 2004 May;58(5):787-95.</citation>
    <PMID>15116082</PMID>
  </reference>
  <reference>
    <citation>Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009 Nov;6(6):790-804.</citation>
    <PMID>20101923</PMID>
  </reference>
  <reference>
    <citation>EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208.</citation>
    <PMID>10109801</PMID>
  </reference>
  <reference>
    <citation>Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care. 1988 Oct;11(9):725-32.</citation>
    <PMID>3066604</PMID>
  </reference>
  <reference>
    <citation>Montori VM, Dinneen SF, Gorman CA, Zimmerman BR, Rizza RA, Bjornsen SS, Green EM, Bryant SC, Smith SA; Translation Project Investigator Group. The impact of planned care and a diabetes electronic management system on community-based diabetes care: the Mayo Health System Diabetes Translation Project. Diabetes Care. 2002 Nov;25(11):1952-7.</citation>
    <PMID>12401738</PMID>
  </reference>
  <reference>
    <citation>Lassmann-Vague V, Guerci B, Hanaire-Broutin H, Pinget M, Renard E, Selam JL, Vague P. Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs. Diabetes Metab. 1997 Jun;23(3):234-50. English, French.</citation>
    <PMID>9234003</PMID>
  </reference>
  <reference>
    <citation>Cho JH, Chang SA, Kwon HS, Choi YH, Ko SH, Moon SD, Yoo SJ, Song KH, Son HS, Kim HS, Lee WC, Cha BY, Son HY, Yoon KH. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care. 2006 Dec;29(12):2625-31.</citation>
    <PMID>17130195</PMID>
  </reference>
  <reference>
    <citation>Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. New-york : Oxford University Press, 1996.</citation>
  </reference>
  <reference>
    <citation>Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med. 1992 Sep 30;11(13):1685-704.</citation>
    <PMID>1485053</PMID>
  </reference>
  <reference>
    <citation>Farmer AJ, Prevost AT, Hardeman W, Craven A, Sutton S, Griffin SJ, Kinmonth AL; Support and Advice for Medication Trial Group. Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract. 2008 Apr 11;9:20. doi: 10.1186/1471-2296-9-20.</citation>
    <PMID>18405345</PMID>
  </reference>
  <reference>
    <citation>Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A; TeleDiab Study Group. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011 Mar;34(3):533-9. doi: 10.2337/dc10-1259. Epub 2011 Jan 25.</citation>
    <PMID>21266648</PMID>
  </reference>
  <reference>
    <citation>Schaepelynck P, Renard E, Jeandidier N, Hanaire H, Fermon C, Rudoni S, Catargi B, Riveline JP, Guerci B, Millot L, Martin JF, Sola A; EVADIAC Group. A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients. Diabetes Technol Ther. 2011 Jun;13(6):657-60. doi: 10.1089/dia.2010.0209. Epub 2011 Apr 6.</citation>
    <PMID>21470000</PMID>
  </reference>
  <reference>
    <citation>Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H; EVADIAC Sensor Study Group. Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care. 2012 May;35(5):965-71. doi: 10.2337/dc11-2021. Epub 2012 Mar 28.</citation>
    <PMID>22456864</PMID>
  </reference>
  <reference>
    <citation>Craig H Mallinckrodt, et al. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal (2008). Volume: 42, Issue: 4, Pages: 303-319 [65] Siddiqui O, Hung HM, O'Neill R. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat. 2009;19(2):227-46.</citation>
  </reference>
  <reference>
    <citation>Freudenheim JL, Johnson NE, Wardrop RL. Misclassification of nutrient intake of individuals and groups using one-, two-, three-, and seven-day food records. Am J Epidemiol. 1987 Oct;126(4):703-13.</citation>
    <PMID>3631059</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2013</study_first_submitted>
  <study_first_submitted_qc>September 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2013</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Education</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Food behaviour</keyword>
  <keyword>Weight</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Glycaemia</keyword>
  <keyword>Self-monitoring blood glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

